speb/financial-data huggingface dataset:
AAJ.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 2825.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Income: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Interest Income: 110936.00
AAJ.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 110936.00
AAJ.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -21808.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Net PPE: 52910.00
AAJ.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -8498.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 2250082.00
AAJ.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -1088412.00
AAJ.AX income_statement (annual, 2024-06-30) — Normalized Income: -1125944.00
AAJ.AX income_statement (annual, 2024-06-30) — Operating Income: -2383243.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 196891506.00
AAJ.AX cash_flow (annual, 2024-06-30) — Other Cash Paymentsfrom Operating Activities: -991063.00
AAJ.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 1146363.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 749054.00
AAJ.AX income_statement (annual, 2024-06-30) — Other Income Expense: 1146363.00
AAJ.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 1146363.00
AAJ.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 1372836.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Other Properties: 42386.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 35116.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 158740.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Payables: 127992.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 127992.00
AAJ.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -1244941.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 23473.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 16875.00
AAJ.AX income_statement (annual, 2024-06-30) — Pretax Income: -1125944.00
AAJ.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -8498.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Receivables: 35116.00
AAJ.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 35340.00
AAJ.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 31811.00
AAJ.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -37175.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -21081117.00
AAJ.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 789623.00
AAJ.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 153633.00
AAJ.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 975067.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Share Issued: 196891506.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 2250082.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 2250082.00
AAJ.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
AAJ.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
AAJ.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Assets: 2407426.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 2250082.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Debt: 5879.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 2250082.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 157344.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 52910.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AAJ.AX balance_sheet (annual, 2024-06-30) — Working Capital: 2197172.00
AAJ.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 231512605.00
AAJ.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.01
AAJ.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 231512605.00
AAJ.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.01
AAL balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -34000000.00
AAL cash_flow (annual, 2021-12-31) — Cash Dividends Paid: 0.00
AAL cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: 0.00
AAL cash_flow (annual, 2021-12-31) — Common Stock Issuance: 460000000.00
AAL cash_flow (annual, 2021-12-31) — Common Stock Payments: -18000000.00
AAL cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -22000000.00
AAL balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 1539000000.00
AAL cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 460000000.00
AAL cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -28000000.00
AAL cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 460000000.00
AAL balance_sheet (annual, 2021-12-31) — Prepaid Assets: 615000000.00
AAL cash_flow (annual, 2021-12-31) — Purchase Of Business: -28000000.00
AAL cash_flow (annual, 2021-12-31) — Purchase Of PPE: -204000000.00
AAL cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -18000000.00
AAL cash_flow (annual, 2021-12-31) — Sale Of Business: 5000000.00
AAL income_statement (annual, 2022-12-31) — +Operating Expense: 7237000000.00
AAL income_statement (annual, 2022-12-31) — +Total Revenue: 48971000000.00
AAL balance_sheet (annual, 2022-12-31) — Accounts Payable: 2149000000.00
AAL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2138000000.00
AAL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -20029000000.00
AAL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 7291000000.00
AAL income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
AAL income_statement (annual, 2022-12-31) — Basic Average Shares: 650345000.00
AAL income_statement (annual, 2022-12-31) — Basic EPS: 0.20
AAL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 408000000.00
AAL cash_flow (annual, 2022-12-31) — Capital Expenditure: -2546000000.00
AAL cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -2546000000.00
AAL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 8785000000.00
AAL balance_sheet (annual, 2022-12-31) — Capital Stock: 6000000.00
AAL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 440000000.00
AAL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 8965000000.00
AAL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
AAL balance_sheet (annual, 2022-12-31) — Cash Financial: 440000000.00
AAL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -2631000000.00
AAL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 636000000.00
AAL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2173000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Account Payable: 360000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -775000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 865000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 10000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Payable: 360000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 360000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Receivables: -637000000.00
AAL cash_flow (annual, 2022-12-31) — Change In Working Capital: -177000000.00
AAL cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -637000000.00
AAL cash_flow (annual, 2022-12-31) — Changes In Cash: 178000000.00
AAL balance_sheet (annual, 2022-12-31) — Common Stock: 6000000.00
AAL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
AAL balance_sheet (annual, 2022-12-31) — Common Stock Equity: -5799000000.00
AAL cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
AAL cash_flow (annual, 2022-12-31) — Common Stock Payments: -21000000.00
AAL balance_sheet (annual, 2022-12-31) — Construction In Progress: 613000000.00
AAL income_statement (annual, 2022-12-31) — Cost Of Revenue: 39934000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 4694000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Assets: 15269000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1681000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Debt: 3059000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4740000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 9914000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 9914000000.00
AAL balance_sheet (annual, 2022-12-31) — Current Liabilities: 21496000000.00
AAL cash_flow (annual, 2022-12-31) — Deferred Income Tax: 65000000.00
AAL cash_flow (annual, 2022-12-31) — Deferred Tax: 65000000.00
AAL cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2298000000.00
AAL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2298000000.00
AAL income_statement (annual, 2022-12-31) — Diluted Average Shares: 655122000.00
AAL income_statement (annual, 2022-12-31) — Diluted EPS: 0.19
AAL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 127000000.00
AAL income_statement (annual, 2022-12-31) — EBIT: 2148000000.00
AAL income_statement (annual, 2022-12-31) — EBITDA: 4446000000.00
AAL balance_sheet (annual, 2022-12-31) — Employee Benefits: 2837000000.00
AAL cash_flow (annual, 2022-12-31) — End Cash Position: 586000000.00
AAL cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2631000000.00
AAL cash_flow (annual, 2022-12-31) — Free Cash Flow: -373000000.00
AAL cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
AAL balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -4585000000.00
AAL balance_sheet (annual, 2022-12-31) — Goodwill: 4091000000.00
AAL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6150000000.00
AAL balance_sheet (annual, 2022-12-31) — Gross PPE: 58323000000.00
AAL income_statement (annual, 2022-12-31) — Gross Profit: 9037000000.00
AAL income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 149000000.00
AAL cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 2000000.00
AAL income_statement (annual, 2022-12-31) — Interest Expense: 1962000000.00
AAL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1962000000.00
AAL income_statement (annual, 2022-12-31) — Interest Income: 216000000.00
AAL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 216000000.00
AAL cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1852000000.00
AAL balance_sheet (annual, 2022-12-31) — Inventory: 2279000000.00
AAL balance_sheet (annual, 2022-12-31) — Invested Capital: 29104000000.00
AAL cash_flow (annual, 2022-12-31) — Investing Cash Flow: 636000000.00
AAL cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
AAL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1069000000.00
AAL balance_sheet (annual, 2022-12-31) — Land And Improvements: 9913000000.00
AAL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 7104000000.00
AAL balance_sheet (annual, 2022-12-31) — Long Term Debt: 31844000000.00
AAL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 38948000000.00
AAL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1069000000.00
AAL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3752000000.00
AAL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -321000000.00
AAL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -21000000.00
AAL balance_sheet (annual, 2022-12-31) — Net Debt: 34463000000.00
AAL income_statement (annual, 2022-12-31) — Net Income: 127000000.00
AAL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 127000000.00
AAL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 127000000.00
AAL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 127000000.00
AAL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 127000000.00
AAL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 127000000.00
AAL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 127000000.00
AAL income_statement (annual, 2022-12-31) — Net Interest Income: -1746000000.00
AAL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 3715000000.00
AAL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2683000000.00
AAL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -2683000000.00
AAL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1746000000.00
AAL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 52000000.00
AAL cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -359000000.00
AAL balance_sheet (annual, 2022-12-31) — Net PPE: 38294000000.00
AAL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 147000000.00
AAL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -11949000000.00
AAL balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 3099000000.00
AAL balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 5976000000.00
AAL balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 5976000000.00
AAL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 3099000000.00
AAL balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2837000000.00
AAL income_statement (annual, 2022-12-31) — Normalized EBITDA: 4639000000.00
AAL income_statement (annual, 2022-12-31) — Normalized Income: 258779569.89
AAL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2173000000.00
AAL cash_flow (annual, 2022-12-31) — Operating Gains Losses: -402000000.00
AAL income_statement (annual, 2022-12-31) — Operating Income: 1800000000.00
AAL income_statement (annual, 2022-12-31) — Operating Revenue: 45801000000.00
AAL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 650642461.00
AAL balance_sheet (annual, 2022-12-31) — Other Current Assets: 892000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 3059000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: -1000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -4585000000.00
AAL income_statement (annual, 2022-12-31) — Other Income Expense: 132000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 2059000000.00
AAL cash_flow (annual, 2022-12-31) — Other Non Cash Items: 184000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1904000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1258000000.00
AAL income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 325000000.00
AAL income_statement (annual, 2022-12-31) — Other Operating Expenses: 5422000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Properties: 8094000000.00
AAL balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 8525000000.00
AAL income_statement (annual, 2022-12-31) — Other Special Charges: 44000000.00
AAL balance_sheet (annual, 2022-12-31) — Payables: 2149000000.00
AAL balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 6843000000.00
AAL cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -405000000.00
AAL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 892000000.00
AAL income_statement (annual, 2022-12-31) — Pretax Income: 186000000.00
AAL cash_flow (annual, 2022-12-31) — Purchase Of Business: -321000000.00
AAL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -11257000000.00
AAL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -360000000.00
AAL balance_sheet (annual, 2022-12-31) — Receivables: 2138000000.00
AAL income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 39934000000.00
AAL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2298000000.00
AAL income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 4130000000.00
AAL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3752000000.00
AAL cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -21000000.00
AAL balance_sheet (annual, 2022-12-31) — Restricted Cash: 995000000.00
AAL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
AAL balance_sheet (annual, 2022-12-31) — Retained Earnings: -8511000000.00
AAL cash_flow (annual, 2022-12-31) — Sale Of Investment: 14972000000.00
AAL cash_flow (annual, 2022-12-31) — Sale Of PPE: 147000000.00
AAL income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1815000000.00
AAL income_statement (annual, 2022-12-31) — Selling General And Administration: 1815000000.00
AAL balance_sheet (annual, 2022-12-31) — Share Issued: 650642461.00
AAL income_statement (annual, 2022-12-31) — Special Income Charges: -193000000.00
AAL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 78000000.00
AAL balance_sheet (annual, 2022-12-31) — Stockholders Equity: -5799000000.00
AAL balance_sheet (annual, 2022-12-31) — Tangible Book Value: -11949000000.00
AAL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -61220430.11
AAL income_statement (annual, 2022-12-31) — Tax Provision: 59000000.00
AAL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.32
AAL balance_sheet (annual, 2022-12-31) — Total Assets: 64716000000.00
AAL balance_sheet (annual, 2022-12-31) — Total Capitalization: 26045000000.00
AAL balance_sheet (annual, 2022-12-31) — Total Debt: 43688000000.00
AAL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -5799000000.00
AAL income_statement (annual, 2022-12-31) — Total Expenses: 47171000000.00
AAL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 70515000000.00
AAL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 49447000000.00
AAL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 49019000000.00
AAL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1607000000.00
AAL income_statement (annual, 2022-12-31) — Total Unusual Items: -193000000.00
AAL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -193000000.00
AAL balance_sheet (annual, 2022-12-31) — Working Capital: -6227000000.00
AAL income_statement (annual, 2023-12-31) — +Operating Expense: 7805000000.00
AAL income_statement (annual, 2023-12-31) — +Total Revenue: 52788000000.00
AAL balance_sheet (annual, 2023-12-31) — Accounts Payable: 2353000000.00
AAL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2026000000.00
AAL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -22097000000.00
AAL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 7374000000.00
AAL income_statement (annual, 2023-12-31) — Basic Average Shares: 653612000.00
AAL income_statement (annual, 2023-12-31) — Basic EPS: 1.26
AAL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 575000000.00
AAL cash_flow (annual, 2023-12-31) — Capital Expenditure: -2542000000.00
AAL cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2542000000.00
AAL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 8267000000.00
AAL balance_sheet (annual, 2023-12-31) — Capital Stock: 7000000.00
AAL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 578000000.00
AAL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 7578000000.00
AAL balance_sheet (annual, 2023-12-31) — Cash Financial: 578000000.00
AAL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -3162000000.00
AAL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -449000000.00
AAL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 3706000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Account Payable: 147000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -2000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -127000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 111000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Payable: 147000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 147000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Receivables: -378000000.00
AAL cash_flow (annual, 2023-12-31) — Change In Working Capital: -249000000.00
AAL cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 104000000.00
AAL cash_flow (annual, 2023-12-31) — Changes In Cash: 95000000.00
AAL balance_sheet (annual, 2023-12-31) — Common Stock: 7000000.00
AAL balance_sheet (annual, 2023-12-31) — Common Stock Equity: -5202000000.00
AAL cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
AAL balance_sheet (annual, 2023-12-31) — Construction In Progress: 760000000.00
AAL income_statement (annual, 2023-12-31) — Cost Of Revenue: 40978000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 5115000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Assets: 13572000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1440000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Debt: 3501000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4941000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 9653000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 9653000000.00
AAL balance_sheet (annual, 2023-12-31) — Current Liabilities: 22062000000.00
AAL cash_flow (annual, 2023-12-31) — Deferred Income Tax: 394000000.00
AAL cash_flow (annual, 2023-12-31) — Deferred Tax: 394000000.00
AAL cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2198000000.00
AAL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2198000000.00
AAL income_statement (annual, 2023-12-31) — Diluted Average Shares: 719669000.00
AAL income_statement (annual, 2023-12-31) — Diluted EPS: 1.21
AAL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 822000000.00
AAL income_statement (annual, 2023-12-31) — EBIT: 3266000000.00
AAL income_statement (annual, 2023-12-31) — EBITDA: 5464000000.00
AAL balance_sheet (annual, 2023-12-31) — Employee Benefits: 3044000000.00
AAL cash_flow (annual, 2023-12-31) — End Cash Position: 670000000.00
AAL cash_flow (annual, 2023-12-31) — Financing Cash Flow: -3162000000.00
AAL cash_flow (annual, 2023-12-31) — Free Cash Flow: 1164000000.00
AAL balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -4894000000.00
AAL balance_sheet (annual, 2023-12-31) — Goodwill: 4091000000.00
AAL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 6142000000.00
AAL balance_sheet (annual, 2023-12-31) — Gross PPE: 60800000000.00
AAL income_statement (annual, 2023-12-31) — Gross Profit: 11810000000.00
AAL income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
AAL cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 6000000.00
AAL income_statement (annual, 2023-12-31) — Interest Expense: 2145000000.00
AAL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2145000000.00
AAL income_statement (annual, 2023-12-31) — Interest Income: 591000000.00
AAL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 591000000.00
AAL cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2180000000.00
AAL balance_sheet (annual, 2023-12-31) — Inventory: 2400000000.00
AAL balance_sheet (annual, 2023-12-31) — Invested Capital: 27194000000.00
AAL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -449000000.00
AAL cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
AAL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 4822000000.00
AAL balance_sheet (annual, 2023-12-31) — Land And Improvements: 10307000000.00
AAL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 6827000000.00
AAL balance_sheet (annual, 2023-12-31) — Long Term Debt: 28895000000.00
AAL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 35722000000.00
AAL cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 4822000000.00
AAL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -7697000000.00
AAL cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
AAL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
AAL balance_sheet (annual, 2023-12-31) — Net Debt: 31818000000.00
AAL income_statement (annual, 2023-12-31) — Net Income: 822000000.00
AAL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 822000000.00
AAL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 822000000.00
AAL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 822000000.00
AAL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 822000000.00
AAL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1188000000.00
AAL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 822000000.00
AAL income_statement (annual, 2023-12-31) — Net Interest Income: -1554000000.00
AAL cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 1588000000.00
AAL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -2875000000.00
AAL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -2875000000.00
AAL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1554000000.00
AAL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -287000000.00
AAL cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 275000000.00
AAL balance_sheet (annual, 2023-12-31) — Net PPE: 38703000000.00
AAL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 230000000.00
AAL cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
AAL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -11344000000.00
AAL balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 2888000000.00
AAL balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 5874000000.00
AAL balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 5874000000.00
AAL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 2888000000.00
AAL balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3044000000.00
AAL income_statement (annual, 2023-12-31) — Normalized EBITDA: 6435000000.00
AAL income_statement (annual, 2023-12-31) — Normalized Income: 1533743000.00
AAL cash_flow (annual, 2023-12-31) — Operating Cash Flow: 3706000000.00
AAL cash_flow (annual, 2023-12-31) — Operating Gains Losses: 253000000.00
AAL income_statement (annual, 2023-12-31) — Operating Income: 4005000000.00
AAL income_statement (annual, 2023-12-31) — Operating Revenue: 49324000000.00
AAL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 654273192.00
AAL balance_sheet (annual, 2023-12-31) — Other Current Assets: 658000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 3501000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -4894000000.00
AAL income_statement (annual, 2023-12-31) — Other Income Expense: -1330000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2051000000.00
AAL cash_flow (annual, 2023-12-31) — Other Non Cash Items: -175000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1753000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1558000000.00
AAL income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -359000000.00
AAL income_statement (annual, 2023-12-31) — Other Operating Expenses: 6006000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Properties: 7939000000.00
AAL balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 7000000000.00
AAL income_statement (annual, 2023-12-31) — Other Special Charges: 948000000.00
AAL balance_sheet (annual, 2023-12-31) — Payables: 2353000000.00
AAL balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 7468000000.00
AAL cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -14000000.00
AAL income_statement (annual, 2023-12-31) — Pretax Income: 1121000000.00
AAL cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
AAL cash_flow (annual, 2023-12-31) — Purchase Of Investment: -7324000000.00
AAL balance_sheet (annual, 2023-12-31) — Receivables: 2026000000.00
AAL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 40978000000.00
AAL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2198000000.00
AAL income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 4297000000.00
AAL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -7697000000.00
AAL balance_sheet (annual, 2023-12-31) — Restricted Cash: 910000000.00
AAL income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 23000000.00
AAL balance_sheet (annual, 2023-12-31) — Retained Earnings: -7689000000.00
AAL cash_flow (annual, 2023-12-31) — Sale Of Investment: 8912000000.00
AAL cash_flow (annual, 2023-12-31) — Sale Of PPE: 230000000.00
AAL income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1799000000.00
AAL income_statement (annual, 2023-12-31) — Selling General And Administration: 1799000000.00
AAL balance_sheet (annual, 2023-12-31) — Share Issued: 654273192.00
AAL cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
AAL income_statement (annual, 2023-12-31) — Special Income Charges: -971000000.00
AAL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 97000000.00
AAL balance_sheet (annual, 2023-12-31) — Stockholders Equity: -5202000000.00
AAL balance_sheet (annual, 2023-12-31) — Tangible Book Value: -11344000000.00
AAL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -259257000.00
AAL income_statement (annual, 2023-12-31) — Tax Provision: 299000000.00
AAL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.27
AAL balance_sheet (annual, 2023-12-31) — Total Assets: 63058000000.00
AAL balance_sheet (annual, 2023-12-31) — Total Capitalization: 23693000000.00
AAL balance_sheet (annual, 2023-12-31) — Total Debt: 40663000000.00
AAL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -5202000000.00
AAL income_statement (annual, 2023-12-31) — Total Expenses: 48783000000.00
AAL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 68260000000.00
AAL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 49486000000.00
AAL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 46198000000.00
AAL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 3034000000.00
AAL income_statement (annual, 2023-12-31) — Total Unusual Items: -971000000.00
AAL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -971000000.00
AAL balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
AAL balance_sheet (annual, 2023-12-31) — Working Capital: -8490000000.00
AAL income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 0.00
AAL cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 0.00
AAL cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 245000000.00
AAL cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 245000000.00
AAL income_statement (annual, 2024-12-31) — +Operating Expense: 8241000000.00
AAL income_statement (annual, 2024-12-31) — +Total Revenue: 54211000000.00
AAL balance_sheet (annual, 2024-12-31) — Accounts Payable: 2455000000.00
AAL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2006000000.00
AAL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -23608000000.00
AAL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 7424000000.00
AAL income_statement (quarterly, 2024-12-31) — Average Dilution Earnings: 51000000.00
AAL income_statement (annual, 2024-12-31) — Basic Average Shares: 656996000.00
AAL income_statement (annual, 2024-12-31) — Basic EPS: 1.29
AAL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 670000000.00
AAL cash_flow (annual, 2024-12-31) — Capital Expenditure: -2624000000.00
AAL cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -2624000000.00
AAL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7731000000.00
AAL balance_sheet (annual, 2024-12-31) — Capital Stock: 7000000.00
AAL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 804000000.00
AAL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6984000000.00
AAL balance_sheet (annual, 2024-12-31) — Cash Financial: 804000000.00
AAL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -2277000000.00
AAL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -909000000.00
AAL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 3409000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Account Payable: 284000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -287000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 405000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 432000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Payable: 284000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 284000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Receivables: -1066000000.00
AAL cash_flow (annual, 2024-12-31) — Change In Working Capital: -232000000.00
AAL cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 33000000.00
AAL cash_flow (annual, 2024-12-31) — Changes In Cash: 223000000.00
AAL balance_sheet (annual, 2024-12-31) — Common Stock: 7000000.00
AAL balance_sheet (annual, 2024-12-31) — Common Stock Equity: -3977000000.00
AAL balance_sheet (annual, 2024-12-31) — Construction In Progress: 1012000000.00
AAL income_statement (annual, 2024-12-31) — Cost Of Revenue: 42746000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 5037000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Assets: 13154000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1224000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Debt: 5270000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6494000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 10315000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 10315000000.00
AAL balance_sheet (annual, 2024-12-31) — Current Liabilities: 24295000000.00
AAL cash_flow (annual, 2024-12-31) — Deferred Income Tax: 426000000.00
AAL cash_flow (annual, 2024-12-31) — Deferred Tax: 426000000.00
AAL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2198000000.00
AAL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2198000000.00
AAL income_statement (annual, 2024-12-31) — Diluted Average Shares: 721300000.00
AAL income_statement (annual, 2024-12-31) — Diluted EPS: 1.24
AAL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 846000000.00
AAL income_statement (annual, 2024-12-31) — EBIT: 3088000000.00
AAL income_statement (annual, 2024-12-31) — EBITDA: 5286000000.00
AAL balance_sheet (annual, 2024-12-31) — Employee Benefits: 2128000000.00
AAL cash_flow (annual, 2024-12-31) — End Cash Position: 893000000.00
AAL cash_flow (annual, 2024-12-31) — Financing Cash Flow: -2277000000.00
AAL cash_flow (annual, 2024-12-31) — Free Cash Flow: 785000000.00
AAL balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -4565000000.00
AAL balance_sheet (annual, 2024-12-31) — Goodwill: 4091000000.00
AAL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 6135000000.00
AAL balance_sheet (annual, 2024-12-31) — Gross PPE: 62068000000.00
AAL income_statement (annual, 2024-12-31) — Gross Profit: 11465000000.00
AAL income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: -42000000.00
AAL cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 8000000.00
AAL cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 2000000.00
AAL income_statement (annual, 2024-12-31) — Interest Expense: 1934000000.00
AAL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1934000000.00
AAL income_statement (annual, 2024-12-31) — Interest Income: 468000000.00
AAL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 468000000.00
AAL cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1933000000.00
AAL cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 421000000.00
AAL balance_sheet (annual, 2024-12-31) — Inventory: 2638000000.00
AAL balance_sheet (annual, 2024-12-31) — Invested Capital: 25910000000.00
AAL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -909000000.00
AAL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1744000000.00
AAL balance_sheet (annual, 2024-12-31) — Land And Improvements: 10202000000.00
AAL balance_sheet (annual, 2024-12-31) — Line Of Credit: 74000000.00
AAL balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 74000000.00
AAL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 6507000000.00
AAL balance_sheet (annual, 2024-12-31) — Long Term Debt: 24617000000.00
AAL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 31124000000.00
AAL cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1670000000.00
AAL cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3973000000.00
AAL cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
AAL balance_sheet (annual, 2024-12-31) — Net Debt: 29083000000.00
AAL income_statement (annual, 2024-12-31) — Net Income: 846000000.00
AAL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 846000000.00
AAL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 846000000.00
AAL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 846000000.00
AAL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 846000000.00
AAL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1262000000.00
AAL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 846000000.00
AAL income_statement (annual, 2024-12-31) — Net Interest Income: -1466000000.00
AAL cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 996000000.00
AAL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2229000000.00
AAL cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2303000000.00
AAL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1466000000.00
AAL cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -48000000.00
AAL cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 65000000.00
AAL balance_sheet (annual, 2024-12-31) — Net PPE: 38460000000.00
AAL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 654000000.00
AAL cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 56000000.00
AAL cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 74000000.00
AAL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -10112000000.00
AAL balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 2485000000.00
AAL balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 6498000000.00
AAL balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 6498000000.00
AAL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 2485000000.00
AAL balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2128000000.00
AAL income_statement (annual, 2024-12-31) — Normalized EBITDA: 5896000000.00
AAL income_statement (annual, 2024-12-31) — Normalized Income: 1293130000.00
AAL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3409000000.00
AAL cash_flow (annual, 2024-12-31) — Operating Gains Losses: -73000000.00
AAL income_statement (annual, 2024-12-31) — Operating Income: 3224000000.00
AAL income_statement (annual, 2024-12-31) — Operating Revenue: 50390000000.00
AAL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 657566166.00
AAL balance_sheet (annual, 2024-12-31) — Other Current Assets: 794000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 5196000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: -6000000.00
AAL balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: -6000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -4565000000.00
AAL income_statement (annual, 2024-12-31) — Other Income Expense: -604000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2044000000.00
AAL cash_flow (annual, 2024-12-31) — Other Non Cash Items: -261000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1549000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1715000000.00
AAL income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 6000000.00
AAL income_statement (annual, 2024-12-31) — Other Operating Expenses: 6429000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Properties: 7333000000.00
AAL balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 6180000000.00
AAL income_statement (annual, 2024-12-31) — Other Special Charges: 639000000.00
AAL balance_sheet (annual, 2024-12-31) — Payables: 2455000000.00
AAL balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 7492000000.00
AAL cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -82000000.00
AAL income_statement (annual, 2024-12-31) — Pretax Income: 1154000000.00
AAL cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
AAL cash_flow (annual, 2024-12-31) — Purchase Of Investment: -7194000000.00
AAL balance_sheet (annual, 2024-12-31) — Receivables: 2006000000.00
AAL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 42746000000.00
AAL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2198000000.00
AAL income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 4545000000.00
AAL cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3973000000.00
AAL balance_sheet (annual, 2024-12-31) — Restricted Cash: 732000000.00
AAL income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 13000000.00
AAL income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
AAL balance_sheet (annual, 2024-12-31) — Retained Earnings: -6843000000.00
AAL cash_flow (annual, 2024-12-31) — Sale Of Investment: 8190000000.00
AAL cash_flow (annual, 2024-12-31) — Sale Of PPE: 654000000.00
AAL cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 56000000.00
AAL income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1812000000.00
AAL income_statement (annual, 2024-12-31) — Selling General And Administration: 1812000000.00
AAL balance_sheet (annual, 2024-12-31) — Share Issued: 657566166.00
AAL cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 74000000.00
AAL income_statement (annual, 2024-12-31) — Special Income Charges: -610000000.00
AAL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 89000000.00
AAL balance_sheet (annual, 2024-12-31) — Stockholders Equity: -3977000000.00
AAL balance_sheet (annual, 2024-12-31) — Tangible Book Value: -10112000000.00
AAL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -162870000.00
AAL income_statement (annual, 2024-12-31) — Tax Provision: 308000000.00
AAL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.27
AAL balance_sheet (annual, 2024-12-31) — Total Assets: 61783000000.00
AAL balance_sheet (annual, 2024-12-31) — Total Capitalization: 20640000000.00
AAL balance_sheet (annual, 2024-12-31) — Total Debt: 37618000000.00
AAL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -3977000000.00
AAL income_statement (annual, 2024-12-31) — Total Expenses: 50987000000.00
AAL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 65760000000.00
AAL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 48629000000.00
AAL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 41465000000.00
AAL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 2614000000.00
AAL income_statement (annual, 2024-12-31) — Total Unusual Items: -610000000.00
AAL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -610000000.00
AAL balance_sheet (annual, 2024-12-31) — Working Capital: -11141000000.00
AAL income_statement (quarterly, 2025-03-31) — +Operating Expense: 2078000000.00
AAL income_statement (quarterly, 2025-03-31) — +Total Revenue: 12551000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3114000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1928000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -23792000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7348000000.00
AAL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 658880000.00
AAL income_statement (quarterly, 2025-03-31) — Basic EPS: -0.72
AAL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 902000000.00
AAL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -824000000.00
AAL cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -824000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 7158000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 835000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7466000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Cash Financial: 835000000.00
AAL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1223000000.00
AAL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1204000000.00
AAL cash_flow (quarterly, 2025-03-31) — Changes In Cash: 29000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Common Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -4508000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1063000000.00
AAL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 10673000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 4578000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Assets: 13603000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1096000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Debt: 4729000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5825000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 12595000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 12595000000.00